Agendia Dec 22, 2020 Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium Nov 18, 2020 Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Aug 26, 2020 Agendia's MammaPrint Breast Cancer Risk Test Cost-Effective in Multi-Country Analysis Jun 12, 2020 New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes Premium May 21, 2019 Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal Oct 10, 2018 NCCN Update on Breast Cancer Genetic Testing Guidelines Marks Oncotype DX as 'Preferred' Test Feb 7, 2018 UK's NICE Finalizing Updated Breast Cancer Test Guidance Following Stakeholder Comments Premium Jul 10, 2017 ASCO Guideline Update Recommends Agendia MammaPrint in 1-3-Node Patients Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
